On Jan. 16, 2024, a panel of the Inquiry Committee approved a Consent Agreement between BCCNM and the Registrant to address practice deficits that occurred between September 2020 and September 2021 related to diverting narcotics from the workplace for a period of 12 months for personal use, under the names of patients who were no longer admitted and/or with no record of administration, and by entering the premises when not scheduled to work, or prior to, or after scheduled shifts.
The Registrant was diagnosed with and admitted to a disability with a causal relationship to the practice issues via an independent medical report and they have agreed to comply with the treatment recommendations.
The Registrant has voluntarily agreed to terms equivalent to a limit and/or condition on their practice, including:
- A Reprimand resulting from their breach of ethical nursing standards related to diverting medication from their workplace for their own use;
- Regular reports from treating physicians regarding compliance with treatment recommendations;
- Disclosure of treatment recommendations to relevant employer representative(s);
- A limit impacting access to and handling of narcotics, with concurrent medical monitoring, to support the stable return to fitness to practice;
- A limit on being the sole RN on duty, working overtime, working on more than one unit, and from being assigned students for two years, a limit on practising in an emergency room for one year, and a limit on working overtime for six months and no nights for three months.
The Agreement will remain in place for a maximum of four years of continuous nursing practice.
The name of the Registrant has been withheld in accordance with section 39.3 (4) (a) of the Health Professions Act for the purposes of not identifying a registrant or their personal health information respecting the condition that impaired their ability to practice nursing or midwifery.
The Inquiry Committee is satisfied that the terms will protect the public.